Published in N Engl J Med on June 17, 1999
Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med (2007) 5.05
Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program. Cardiovasc Drugs Ther (2015) 1.41
How well is the clinical importance of study results reported? An assessment of randomized controlled trials. CMAJ (2001) 1.31
The evaluation and management of electrical storm. Tex Heart Inst J (2011) 1.13
Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart (2007) 0.95
Implantable cardioverter-defibrillators. Heart (2001) 0.82
Optimal antiarrhythmic drug therapy for electrical storm. J Biomed Res (2015) 0.82
Recollection of pain due to inappropriate versus appropriate implantable cardioverter-defibrillator shocks. Pacing Clin Electrophysiol (2010) 0.81
Rationale and design of a randomized clinical trial comparing stress reduction treatment to usual cardiac care: the Reducing Vulnerability to Implantable Cardioverter Defibrillator Shock-Treated Ventricular Arrhythmias (RISTA) trial. Psychosom Med (2009) 0.80
Role of catheter ablation of ventricular tachycardia associated with structural heart disease. World J Cardiol (2011) 0.78
Redefining the role of antiarrhythmic drugs. N Engl J Med (1999) 0.78
Current and emerging antiarrhythmic drug therapy for ventricular tachycardia. Cardiol Ther (2013) 0.76
Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol (2015) 0.76
Effect of spironolactone on ventricular arrhythmias in patients with left ventricular systolic dysfunction and implantable cardioverter defibrillators. Indian Heart J (2012) 0.75
Pharmacotherapy to reduce arrhythmic mortality. Indian Heart J (2014) 0.75
Antiarrhythmic Drug Therapy to Avoid Implantable Cardioverter Defibrillator Shocks. Arrhythm Electrophysiol Rev (2016) 0.75
Impact of Magnesium L-Lactate on Occurrence of Ventricular Arrhythmias in Patients with Implantable Cardioverter Defibrillators: A Randomized, Placebo-Controlled Trial. Open Cardiovasc Med J (2015) 0.75
Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes. Heart Fail Rev (2011) 0.75
Atrial fibrillation in heart failure: drug therapies for rate and rhythm control. Heart Fail Rev (2014) 0.75
The Significance of Shocks in Implantable Cardioverter Defibrillator Recipients. Arrhythm Electrophysiol Rev (2016) 0.75
Single-chamber versus dual-chamber implantable cardioverter defibrillators: do we need physiologic pacing in the course? Indian Pacing Electrophysiol J (2006) 0.75
Management of ventricular tachycardia in heart failure. Methodist Debakey Cardiovasc J (2013) 0.75
Device based treatment of heart failure. Postgrad Med J (2005) 0.75
Aborted sudden cardiac death: a clinical perspective. Postgrad Med J (2001) 0.75
[Electrical storm in ICD patients: prevention and treatment]. Herzschrittmacherther Elektrophysiol (2014) 0.75
Management of ventricular tachycardia storm in patients with structural heart disease. World J Cardiol (2017) 0.75
Rationale and patient selection for "hybrid" drug and device therapy in atrial and ventricular arrhythmias. J Interv Card Electrophysiol (2003) 0.75
Ranolazine: safe and effective in a patient with hypertensive cardiomyopathy and multiple episodes of electrical storm. Clin Case Rep (2017) 0.75
[Electrical storm: definition, prevalence, causes and prognostic implications]. Herzschrittmacherther Elektrophysiol (2014) 0.75
Ventricular tachycardia inducibility after radiofrequency ablation affects the outcomes in patients with coronary artery disease and implantable cardioverter-defibrillators: The role of left ventricular function. J Interv Card Electrophysiol (2009) 0.75
The future of implantable defibrillator and cardiac resynchronization therapy trials. J Interv Card Electrophysiol (2008) 0.75
The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure. Heart Fail Rev (2016) 0.75
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med (1996) 15.04
A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (1999) 10.17
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med (1996) 10.09
Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst (1996) 5.63
Subepithelial fibrosis in the bronchi of asthmatics. Lancet (1989) 3.70
Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. N Engl J Med (1981) 3.30
Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol (1980) 3.14
Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med (2000) 2.80
The Brighton resuscitation ambulances: a continuing experiment in prehospital care by ambulance staff. Br Med J (1976) 2.66
Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation (1998) 2.59
Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol (1998) 2.50
Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation (2001) 2.50
Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J Clin Invest (1987) 2.48
Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature (1990) 2.46
Hospital resuscitation from ventricular fibrillation in Brighton. Br Med J (1979) 2.43
APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model. Neurology (2005) 2.31
ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol (1998) 2.27
A common polymorphism associated with antibiotic-induced cardiac arrhythmia. Proc Natl Acad Sci U S A (2000) 2.26
The Brighton resuscitation ambulances: review of 40 consecutive survivors of out-of-hospital cardiac arrest. Br Med J (1978) 2.24
"Kiss and run" exocytosis at hippocampal synapses. Proc Natl Acad Sci U S A (2000) 2.01
Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism. J Clin Invest (1980) 1.84
Behavioral responses to artificial food colors. Science (1980) 1.82
An improved basis for enzymatic estimation of infarct size. Circulation (1975) 1.77
Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model. J Cardiovasc Electrophysiol (1997) 1.74
Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies. J Clin Pathol (1994) 1.72
Wilson's disease with superimposed autoimmune features: report of two cases and review. J Gastroenterol Hepatol (2000) 1.70
Incivility in the workplace: incidence and impact. J Occup Health Psychol (2001) 1.68
Long-term outcome of patients with drug-refractory atrial flutter and fibrillation after single- and dual-site right atrial pacing for arrhythmia prevention. J Am Coll Cardiol (1998) 1.67
Effects of nifedipine on myocardial perfusion and ischemic injury in dogs. Circ Res (1978) 1.67
Myocardial contracture and accumulation of mitochondrial calcium in ischemic rabbit heart. Am J Physiol (1977) 1.65
E-C coupling failure in mouse EDL muscle after in vivo eccentric contractions. J Appl Physiol (1985) (1998) 1.62
Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110. Circ Res (1986) 1.59
Risk of development of delayed atrioventricular block after slow pathway modification in patients with atrioventricular nodal reentrant tachycardia and a pre-existing prolonged PR interval. Eur Heart J (2001) 1.57
Is gall bladder ejection fraction a reliable predictor of acalculous gall bladder disease? Nucl Med Commun (1992) 1.57
Interaction between electronic article surveillance systems and implantable defibrillators: insights from a fourth generation ICD. Pacing Clin Electrophysiol (1997) 1.54
Dexamethasone iontophoresis: effect on delayed muscle soreness and muscle function. Can J Sport Sci (1992) 1.51
Maintenance of sinus rhythm with oral d,l-sotalol therapy in patients with symptomatic atrial fibrillation and/or atrial flutter. d,l-Sotalol Atrial Fibrillation/Flutter Study Group. Am J Cardiol (1999) 1.49
Asymptomatic Wolff-Parkinson-White. Should we intervene? Circulation (1989) 1.47
Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol (1982) 1.45
In vivo attenuation of simian immunodeficiency virus by disruption of a tyrosine-dependent sorting signal in the envelope glycoprotein cytoplasmic tail. J Virol (2001) 1.45
Report of the NASPE policy conference on arrhythmias and the athlete. J Cardiovasc Electrophysiol (2001) 1.44
Circadian variation of heart rate variability in postinfarction patients with and without life-threatening ventricular tachyarrhythmias. J Cardiovasc Electrophysiol (1995) 1.41
Using behavioural ecology to understand depression. Br J Psychiatry (1998) 1.40
Management of atrial fibrillation: simplicity surrounded by controversy. Ann Intern Med (1997) 1.39
Evaluation of antiarrhythmic drug efficacy in patients with an ICD: unlimited potential or replete with complexity and problems? J Cardiovasc Electrophysiol (1999) 1.39
The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias. Am Heart J (1989) 1.38
Contractile properties of skinned fibers from hypertrophied skeletal muscle. Med Sci Sports Exerc (1993) 1.38
Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (2001) 1.38
Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. J Clin Invest (1981) 1.37
ESCWGA/NASPE/P experts consensus statement: living anatomy of the atrioventricular junctions. A guide to electrophysiologic mapping. Working Group of Arrhythmias of the European Society of Cardiology. North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (1999) 1.37
Non-alcoholic steatohepatitis: definitions and pathogenesis. J Gastroenterol Hepatol (2002) 1.36
Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet (2000) 1.35
Videomicroscopic demonstration of defective cholinergic arteriolar vasodilation in atherosclerotic rabbit. J Clin Invest (1988) 1.34
Analysis of 12-lead T-wave morphology for risk stratification after myocardial infarction. Circulation (2000) 1.30
Continuous axenic cultivation of Pneumocystis carinii. Proc Natl Acad Sci U S A (1999) 1.29
[Guidelines for the implantation of defibrillators]. Clin Res Cardiol (2006) 1.28
Regional right and left atrial activation patterns during single- and dual-site atrial pacing in patients with atrial fibrillation. Am J Cardiol (1998) 1.26
NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine. Food Addit Contam Part A Chem Anal Control Expo Risk Assess (2008) 1.25
Contractile responses of smooth muscle strips from rat and guinea-pig urinary bladder to transmural stimulation: effects of atropine and alpha,beta-methylene ATP. Br J Pharmacol (1990) 1.24
Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. J Am Coll Cardiol (1997) 1.24
Arabidopsis gene and cDNA encoding cell-wall invertase. Plant Physiol (1994) 1.23
Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut (2005) 1.19
Safety evaluation of tocainide in the American Emergency Use Program. Am Heart J (1980) 1.18
A simple bedside test of 1-minute heart rate variability during deep breathing as a prognostic index after myocardial infarction. Am Heart J (1999) 1.18
Coronary atherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation (1994) 1.17
Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol (1990) 1.17
Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal subjects. Am J Cardiol (1994) 1.15
Association between atrial fibrillation and appropriate implantable cardioverter defibrillator therapy: results from a prospective study. J Cardiovasc Electrophysiol (2000) 1.15
Intratracheal administration of endotoxin and cytokines. VI. Antiserum to CINC inhibits acute inflammation. Am J Physiol (1995) 1.14
Eccentric contraction-induced injury in normal and hindlimb-suspended mouse soleus and EDL muscles. J Appl Physiol (1985) (1994) 1.14
Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol (1984) 1.14
Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope. Am J Med (1982) 1.14
Evaluation of the purity of cholesterol primary standards. Clin Chem (1970) 1.13
Report of the NASPE Policy Conference on antibradycardia pacemaker follow-up: effectiveness, needs, and resources. North American Society of Pacing and Electrophysiology. Pacing Clin Electrophysiol (1994) 1.13
Effect of ibuprofen use on muscle soreness, damage, and performance: a preliminary investigation. Med Sci Sports Exerc (1993) 1.12
Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device. J Am Coll Cardiol (2001) 1.11
A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy. J Hepatol (1993) 1.11
Prepation of hypercholesterolemic and-or hypertriglyceridemic sera for lipid determinations. Clin Chim Acta (1970) 1.10
Innovative solutions to novel drug development in mental health. Neurosci Biobehav Rev (2013) 1.08
Sensitization of isolated canine coronary arteries to calcium ions after exposure to cholesterol. Circ Res (1979) 1.05
Pace-termination and pacing for prevention of atrial tachyarrhythmias: results from a multicenter study with an implantable device for atrial therapy. J Cardiovasc Electrophysiol (2001) 1.05
Death in the dental chair. Anaesthesia (1999) 1.05
Quantification of serum creatine phosphokinase isoenzyme activity. Am J Cardiol (1974) 1.05
Localized amyloidosis of the lower genitourinary tract: a clinicopathological and immunohistochemical study of nine cases. Histopathology (1992) 1.05
Normal axial relationships of the major joints. Radiology (1966) 1.04
Pneumococcal vaccine and patients with chronic lung disease. Ann Intern Med (1986) 1.04
Effects of intravenous and chronic oral verapamil administration in patients with supraventricular tachyarrhythmias. Circulation (1980) 1.03
Homocysteine and cognitive decline in healthy elderly. Dement Geriatr Cogn Disord (2001) 1.03
Oxidized low-density lipoproteins inhibit endothelial cell proliferation by suppressing basic fibroblast growth factor expression. Circulation (2000) 1.02
Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells. EMBO J (1997) 1.02